{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:11:17Z","timestamp":1789456277796,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00890-7","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:37:29Z","timestamp":1789454249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure-guided identification and experimental validation of NAT10-targeting small molecules in colorectal cancer cells"],"prefix":"10.1007","volume":"40","author":[{"given":"Chao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bensheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"890_CR1","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Translational Oncol 14:101174","journal-title":"Translational Oncol"},{"key":"890_CR2","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/pharmaceutics15112620","volume":"15","author":"A.S Adebayo","year":"2023","unstructured":"Adebayo A.S., Agbaje K, Adesina SK, Olajubutu O (2023) Colorectal cancer: disease process, current treatment options, and future perspectives. Pharmaceutics 15:2620","journal-title":"Pharmaceutics"},{"key":"890_CR3","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.3390\/cancers13133372","volume":"13","author":"V De Paolis","year":"2021","unstructured":"De Paolis V, Lorefice E, Orecchini E, Carissimi C, Laudadio I, Fulci V (2021) Epitranscriptomics: a new layer of microRNA regulation in cancer. Cancers 13:3372","journal-title":"Cancers"},{"key":"890_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/genes10010052","volume":"10","author":"S Dinescu","year":"2019","unstructured":"Dinescu S, Ignat S, Lazar AD, Constantin C, Neagu M, Costache M (2019) Epitranscriptomic signatures in lncRNAs and their possible roles in cancer. Genes 10:52","journal-title":"Genes"},{"key":"890_CR5","doi-asserted-by":"publisher","first-page":"628415","DOI":"10.3389\/fcell.2021.628415","volume":"9","author":"S Kumar","year":"2021","unstructured":"Kumar S, Mohapatra T (2021) Deciphering epitranscriptome: modification of mRNA bases provides a new perspective for post-transcriptional regulation of gene expression. Front cell Dev biology 9:628415","journal-title":"Front cell Dev biology"},{"key":"890_CR6","doi-asserted-by":"publisher","first-page":"e70015","DOI":"10.1002\/mco2.70015","volume":"6","author":"Q Wang","year":"2025","unstructured":"Wang Q, Yuan Y, Zhou Q, Jia Y, Liu J, Xiao G, Li C, Jiang X (2025) RNA N4-acetylcytidine modification and its role in health and diseases. MedComm 6:e70015","journal-title":"MedComm"},{"key":"890_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-025-00286-3","volume":"6","author":"L Jiao","year":"2025","unstructured":"Jiao L, Si Y, Yuan Y, Lei X, Jiang Q, Yang L, Mao W, Ying B, Ma L, Sun T (2025) Emerging role of N-acetyltransferase 10 in diseases: RNA ac4C modification and beyond. Mol Biomed 6:46","journal-title":"Mol Biomed"},{"key":"890_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.01.037","volume":"20","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, Duan S (2020) The processing, gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: a systematic review. Mol therapy Nucleic acids 20:13\u201324","journal-title":"Mol therapy Nucleic acids"},{"key":"890_CR9","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.tranon.2024.101934","volume":"45","author":"C Jin","year":"2024","unstructured":"Jin C, Gao J, Zhu J, Ao Y, Shi B, Li X (2024) Exosomal NAT10 from esophageal squamous cell carcinoma cells modulates macrophage lipid metabolism and polarization through ac4C modification of FASN. Translational Oncol 45:101934","journal-title":"Translational Oncol"},{"key":"890_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12935-021-02124-2","volume":"21","author":"W Tao","year":"2021","unstructured":"Tao W, Tian G, Xu S, Li J, Zhang Z, Li J (2021) NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC. Cancer Cell Int 21:413","journal-title":"Cancer Cell Int"},{"key":"890_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12672-025-02617-w","volume":"16","author":"X Zhou","year":"2025","unstructured":"Zhou X, Sang X, Jiang L, Zhang S, Jiang C, Gu Y, Fu Y, Yang G, Zhang J, Chi H (2025) Deciphering the role of acetylation-related gene NAT10 in colon cancer progression and immune evasion: implications for overcoming drug resistance. Discover Oncol 16:774","journal-title":"Discover Oncol"},{"key":"890_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41392-023-01548-8","volume":"8","author":"W Qian","year":"2023","unstructured":"Qian W, Zhang Y, Hu L, Chen S, Xia Y (2023) A new wave of innovations within the DNA damage response. Signal Transduct Target therapy 8:338","journal-title":"Signal Transduct Target therapy"},{"key":"890_CR13","doi-asserted-by":"publisher","first-page":"14672","DOI":"10.3390\/ijms232314672","volume":"23","author":"D Jurkovicova","year":"2022","unstructured":"Jurkovicova D, Neophytou CM, Ga\u0161parovi\u0107 A\u010c, Gon\u00e7alves AC (2022) DNA damage response in cancer therapy and resistance: challenges and opportunities. Int J Mol Sci 23:14672","journal-title":"Int J Mol Sci"},{"key":"890_CR14","doi-asserted-by":"publisher","first-page":"100783","DOI":"10.1016\/j.tranon.2020.100783","volume":"13","author":"Y Cao","year":"2020","unstructured":"Cao Y, Yao M, Wu Y, Ma N, Liu H, Zhang B (2020) N-acetyltransferase 10 promotes micronuclei formation to activate the senescence-associated secretory phenotype machinery in colorectal cancer cells. Translational Oncol 13:100783","journal-title":"Translational Oncol"},{"key":"890_CR15","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s42003-022-03868-x","volume":"5","author":"H Zhang","year":"2022","unstructured":"Zhang H, Chen Z, Zhou Ja, Gu J, Wu H, Jiang Y, Gao S, Liao Y, Shen R, Miao C (2022) NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway. Commun biology 5:916","journal-title":"Commun biology"},{"key":"890_CR16","doi-asserted-by":"publisher","first-page":"1623276","DOI":"10.3389\/fcell.2025.1623276","volume":"13","author":"D Qin","year":"2025","unstructured":"Qin D, Liu Q, Ma X, Wang R, Lu T, Yang Y, Tang Z, Zhu Y (2025) Research progress on NAT10-mediated acetylation in normal development and disease. Front Cell Dev Biology 13:1623276","journal-title":"Front Cell Dev Biology"},{"key":"890_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s12672-024-01584-y","volume":"15","author":"W Xu","year":"2024","unstructured":"Xu W, Li W, Li Y, Kuai D, Sun W, Liu X, Xu B (2024) Genetic insights into blood protein correlations with colorectal cancer: a Mendelian randomization study. Discover Oncol 15:710","journal-title":"Discover Oncol"},{"key":"890_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13578-025-01504-9","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang S, Liu M, Zhang C, Huang Z, Dai F, Li D, Li H (2025) The function of NAT10-driven N4-acetylcytidine modification in cancer: novel insights and potential therapeutic targets. Cell Bioscience 15:165","journal-title":"Cell Bioscience"},{"key":"890_CR19","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/jcb.30155","volume":"122","author":"MH Dalhat","year":"2021","unstructured":"Dalhat MH, Mohammed MRS, Ahmad A, Khan MI, Choudhry H (2021) Remodelin, a N-acetyltransferase 10 (NAT10) inhibitor, alters mitochondrial lipid metabolism in cancer cells. J Cell Biochem 122:1936\u20131945","journal-title":"J Cell Biochem"},{"key":"890_CR20","doi-asserted-by":"publisher","first-page":"101241","DOI":"10.1016\/j.drup.2025.101241","volume":"81","author":"Z Xu","year":"2025","unstructured":"Xu Z, Zhu M, Geng L, Zhang J, Xia J, Wang Q, An H, Xia A, Yu Y, Liu S (2025) Targeting NAT10 attenuates homologous recombination via destabilizing DNA: RNA hybrids and overcomes PARP inhibitor resistance in cancers. Drug Resist Updates 81:101241","journal-title":"Drug Resist Updates"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00890-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00890-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00890-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:37:30Z","timestamp":1789454250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00890-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00890-7","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest in this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"233"}}